Carlos Bonorino Udaondo. Palabras claves. Over the past decade, notable improvements have been accomplished within the therapeutic algorithm for EoE, including the acceptance of proton pump inhibitor drugs as an anti-inflammatory therapeutic asset, the development of steroid therapy specifically designed for topical delivery, the simplification and optimization of elimination diet schemes, aside from the recognition of endoscopic dilation as a highly effective and safe coadyuvant therapy. This review aims to update and gather, from a practical standpoint, the main therapeutic strategies available for this novel and intriguing disease. Key words. IBP: inhibidor de la bomba de protones.
|Published (Last):||22 August 2006|
|PDF File Size:||14.51 Mb|
|ePub File Size:||5.17 Mb|
|Price:||Free* [*Free Regsitration Required]|
If you are not a health professional and you are visiting this site, you should know that the provided information can never replace the relationship between you and your doctor. Under no circumstances does it redistribute, sell, or make any kind of transfer of information obtained from visitors.
In accordance with the current legislation, if you have voluntarily submitted information to our site, you can use your right to modify it or cancel it by contacting the technical team of this website.
This does not involve any property or responsibility of this journal site on the content of such links, neither on the updating or access conditions. Linking from external sites Linking to this website is permitted, and we promote and encourage it.
There is no need of previous approval of any kind to link us. This could be a problem when linking to us from websites that use frames. In case that you have technical problems to achieve this, even when you are trying to link us out of any frame, please contact us. Included links lead directly to the companies and organizations websites where this material is offered. The visitor accessing these links should carefully follow the instructions provided for each company to access their software.
The journal EP Editorial Board is beyond any possible relationships generated between visitors and those entities. For any question please send an email using the mail form that we offer. The relationship between the magazine and the authors will be regulated as it is described below. Any use of these manuscripts must recognize this authorship in an explicit manner.
The management of the manuscripts is left to the publisher as an exclusive competence. Any use outside these limits must have prior permission of the publisher. In some cases the copy and use may be abide by payment of economic rights that the publisher will manage in common with the authors, according to the publisher standards.
In this case it could be formalized as a publishing rights management contract.
Esofagite eosinofílica: definição e tratamentos
Dietas de eliminación empírica de alimentos en la esofagitis eosinofilica